Baird Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $21

Benzinga Newsdesk www.benzinga.com Positive 67.8%

Neg 0% Neu 0% Pos 67.8%

Baird analyst Vikram Malhotra maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $20 to $21.